Anti-CLEC9A [8F9]
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (4)
- Inventor Info
Info
Catalogue Number | 151707 |
Applications | FACS IHC IF |
Antigen/Gene or Protein Targets | Human DNGR1 |
Reactivity | Human |
Relevance | Recognises human DNGR-1, also known as CLEC9A, which is a highly specific marker of a human DC subset, as well as a receptor able to recognise a preformed signal exposed on necrotic cells. |
Host | Mouse |
Immunogen | RBL-2H3 cells expressing human DNGR-1 fused to an HA epitope |
Positive Control | Mouse IgG2a isotype-matched control mAbs |
Subclass | IgG2a |
Myeloma Used | Sp2/0-Ag14 |
Recommended Growing Conditions | RPMI + 10% FCS + Pen + Strep + Glutamine + 2-ME |
Strain | Balb/c |
Notes | Block Fc receptor prior to staining to reduce background. |
Research Area | Immunology, Stem Cell Biology |
References: 4 entries
Poulin et al. 2010. J Exp Med. 207:1261-71. [PMID: 20479117]
Sancho et al. 2008. J Clin Invest 118:2098-110 .[PMID: 18497879]
Sancho et al. 2009. Nature. 458:899-903. [PMID: 19219027]
Canavan et al. 2018. JCI Insight. 3(23):. PMID: 30518680.
FACS IHC
Add a reference
References: 4 entries
Poulin et al. 2010. J Exp Med. 207:1261-71. [PMID: 20479117]
Sancho et al. 2008. J Clin Invest 118:2098-110 .[PMID: 18497879]
Sancho et al. 2009. Nature. 458:899-903. [PMID: 19219027]
Canavan et al. 2018. JCI Insight. 3(23):. PMID: 30518680.
FACS IHC
Add a reference